I agree that this site is using cookies. You can find further informations here.
X
Shadman, Mazyar
239  results:
Search for persons X
?
1

Real-world and clinical trial outcomes in large B-cell lymp..:

Locke, Frederick L. ; Siddiqi, Tanya ; Jacobson, Caron A....
Blood.  143 (2024)  26 - p. 2722-2734 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Answering the "Doctor, can CAR-T therapy cause cancer?" que..:

Banerjee, Rahul ; Poh, Christina ; Hirayama, Alexandre V....
Blood Advances.  8 (2024)  4 - p. 895-898 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Early Prediction of Severe Icans after CD19 CAR T-Cell Ther..:

Huang, Jennifer J ; Liang, Emily C. ; Albittar, Aya...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S193-S194 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Identification and Prediction of Severe Hematologic Toxicit..:

Liang, Emily C. ; Albittar, Aya ; Portuguese, Andrew J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S180-S181 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Characterization of zanubrutinib safety and tolerability pr..:

Brown, Jennifer R. ; Ghia, Paolo ; Jurczak, Wojciech...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
6

CD19-Directed CART Therapy for T Cell/Histiocyte Rich Large..:

Fein, Dr. Joshua A ; Pophali, Priyanka A. ; Ahn, Kwang...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S356 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Mosunetuzumab Safety Profile in Patients With Relapsed/Refr..:

Matasar, Matthew ; Bartlett, Nancy L. ; Shadman, Mazyar...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  4 - p. 240-253 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Outcomes of Large B-Cell Lymphoma (LBCL) Patients with Seco..:

Hashmi, Hamza ; Epperla, Narendranath ; Ahn, Kwang...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S42 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Post-CAR-T Checkpoint Inhibition Can Result in Durable Resp..:

Banerjee, Rahul ; Lynch, Ryan C ; Wu, Qian Vicky...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S399-S400 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Erratum to: Ultra-deep mutational landscape in chronic lymp..:

Woolston, David W. ; Lee, Nathan D. ; Shadman, Mazyar...
Haematologica.  109 (2024)  7 - p. 2378-2378 , 2024
Link: https://doi.org/10.3324/..
 
?
11

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Su..:

Ho, Carrie ; Gopal, Ajay K. ; Till, Brian G....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. e33-e39.e1 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology.  20 (2024)  12 - p. 717-726 , 2024
Link: https://doi.org/10.2217/..
 
?
13

Real-World Tisagenlecleucel Outcomes in Richter-Transformed..:

Shadman, Mazyar ; Frigault, Matthew J. ; Foley, Stephen Ronan...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S189-S190 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Timing of anti–PD-L1 antibody initiation affects efficacy/t..:

Hirayama, Alexandre V. ; Kimble, Erik L. ; Wright, Jocelyn H....
Blood Advances.  8 (2024)  2 - p. 453-467 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Identification of Predictors of CRS and Neurotoxicity Durat..:

Albittar, Aya ; Voutsinas, Jenna M ; Portuguese, Andrew J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S175 , 2024
Link: https://doi.org/10.1016/..
 
1-15